26 Unidentified Bacterial Species Detected in NASA Cleanroom
A group of scientists at NASA's Jet Propulsion Laboratory, as well as other institutes in India and Saudi Arabia, discovered 26 previously unknown bacterial species in the cleanroom used to assemble the Phoenix spacecraft ahead of its launch in August 2007. The discovery, recently published in the journal Microbiome, highlights the potential risk posed by highly resilient microorganisms that could contaminate space missions or the planets they visit.
For the study, the team of scientists sequenced 215 bacterial strains. Some of these were present before the Phoenix spacecraft arrived at its cleanroom on April 25, 2007, while others formed during the spacecraft's assembly and testing, and after it had been moved to the launchpad to begin its journey to Mars. Out of the 215 strains, the team identified 53 strains belonging to 26 new species.
'Our study aimed to understand the risk of extremophiles being transferred in space missions and to identify which microorganisms might survive the harsh conditions of space,' Alexandre Rosado, a researcher at the King Abdullah University of Science and Technology (KAUST), and lead author of the study, said in a statement. 'This effort is pivotal for monitoring the risk of microbial contamination and safeguarding against unintentional colonization of exploring planets.'
NASA cleanrooms are harsh environments for life, with carefully controlled temperature, humidity, and airflow to keep out dust and bacteria. The type of microorganisms that can survive in a cleanroom may also be equipped to make it in space. Many of the newly identified microorganisms that were growing in the NASA cleanroom were especially resilient against decontamination and radiation. The hardy bacteria carried a unique genetic defense system with traits like DNA repair, enhanced metabolism, and the ability to detoxify harmful molecules. These little guys are what Destiny's Child was singing about with their hit 'Survivor.'
Aside from highlighting the potential impact of these bacteria in space, the new discovery could also have applications on Earth. 'Space travel provides an opportunity to study microorganisms that possess relevant stress-resistance genes,' Junia Schultz, a postdoctoral fellow at KAUST, and first author of the study, said in a statement. 'The genes identified in these newly discovered bacterial species could be engineered for applications in medicine, food preservation, and other industries.'
NASA, it would seem, may also need to go back to the drawing board when it comes to its cleanroom design.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
4 minutes ago
- Medscape
These Two Simple Interventions May Cut CRC Recurrence Risk
This transcript has been edited for clarity. Hello. I'm Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School and Old Dominion University in Norfolk, Virginia. New guidelines have lowered the age to begin screening for colon cancer to 45 years old. Although this change is positive, we're still seeing advanced cancer in younger patients who haven't been screened in time. Once diagnosed, these patients undergo surgery and chemotherapy and often return to us asking, 'What can I do now to help myself?' Two recent studies highlight interventions that are simple, affordable, and actionable today: exercise and aspirin. Let's take a closer look at the results. Exercise's Risk Reduction Potential The idea that exercise reduces cancer recurrence and mortality is supported by observational data. The mechanistic effects behind this have been ascribed to metabolic growth factors, inflammatory changes, immune function changes, and perhaps even positive impact on sleep. A study just published in The New England Journal of Medicine examined structured exercise after adjuvant chemotherapy for colon cancer. The phase 3 randomized CHALLENGE trial, mostly conducted at Canadian and Australian centers, recruited patients with resected stage II or III colon cancer (9.8% and 90.2%, respectively) who had completed adjuvant chemotherapy. Patients with recurrences within a year of diagnosis were excluded, as they were more likely to have highly aggressive, biologically active disease. Patients were randomized to receive healthcare education materials alone or in conjunction with a structured exercise program over a 3-year follow-up period. The exercise intervention, delivered in person or virtually, focused on increasing recreational aerobic activity over baseline by at least 10 metabolic equivalent task (MET). An increment of 10 MET hours per week is not too vigorous. It is essentially the equivalent of adding about 45-60 minutes of brisk walking or 25-30 minutes of jogging 3-4 times a week. Patients were asked to increase MET over the first 6 months and then maintain or further increase the amount over the next 2.5 years. They were permitted to structure their own exercise program by choosing the type, frequency, intensity, and duration of aerobic exercise. The primary endpoint was disease-free survival, with secondary endpoints assessing overall survival, patient-reported outcomes, and other outcomes. Although designed to detect differences at 3 years, follow-up was also performed out to 5 and 8 years. At a median follow-up of 7.9 years, exercise reduced the relative risk of disease recurrence, new primary cancer, or death by 28% ( P =.02). This benefit persisted — and even strengthened — over time, with disease-free survival increasing by 6.4 and 7.1 percentage points at 5 and 8 years, respectively. Musculoskeletal adverse events were slightly higher in the exercise group compared with the health education group (18.5% vs 11.5%, respectively), but only 10% were directly attributed to the exercise. There are considerations when interpreting these results. First, there was an attrition over time for compliance and training. It would be interesting to see whether that impacted the results. Second, it's unclear whether patient pedigree or a genomic pathway may predispose to a benefit here for the exercise group. But overall, this phase 3 trial provides class 1 evidence supporting exercise as a low-cost, high-impact intervention to reduce cancer recurrence. Adjuvant Aspirin in Colon Cancer Subset That's a perfect segue into another recent study looking at the effects of adjuvant aspirin on the prevention of recurrence. The ALASCCA trial— conducted across centers in Sweden, Denmark, Finland, and Norway — assessed patients with stage I-III rectal cancer or stage II-III colon cancer. It focused on a subset of patients with an oncogenic abnormality called PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha). PIK3CA occurs in approximately a third of colon cancers and is associated with significant chemotherapy resistance and a higher rate of disease progression. Of the included patients, 1103 (37%) had alterations in the PIK3CA pathway. Researchers randomized patients to receive either 160 mg of aspirin or placebo daily for 3 years, starting within 3 months of surgery. Among patients with PIK3CA mutations, aspirin dramatically reduced the risk for time to recurrence by nearly 50% at 3 years ( P =.044). Adverse events associated with aspirin were minimal, including one case each of gastrointestinal bleeding, hematoma, and allergic reaction. There is no evidence that higher aspirin doses provide greater prevention of colorectal cancer recurrence. The 160 mg use in the current study is fairly normal, roughly equivalent to two low-dose (81 mg) aspirin tablets. Now, it's worth noting that the use of aspirin for the primary prevention of cardiovascular disease was initially recommended by the US Preventive Task Services Force in 2016. This recommendation was then recanted in 2022, when the same group reported limited net benefit to this approach. Two Proactive Actions These studies highlight two interventions — exercise and aspirin — that are low cost, accessible, and appeal to patients eager to help prevent their cancer from recurring. Exercise is broadly beneficial and can be recommended immediately. For aspirin, patients should work with their oncologist to determine their PIK3CA mutation status, as this subgroup appears to benefit the most. These findings offer patients meaningful, proactive interventions they can apply to support their recovery and reduce the risk of recurrence. Hopefully these new findings will help guide your clinical conversations. I'm Dr David Johnson. Thanks for listening.
Chicago Tribune
34 minutes ago
- Chicago Tribune
Russian and US space chiefs meet to discuss continued cooperation
MOSCOW — Russia's space chief has visited the United States to discuss plans for continued cooperation between Moscow and Washington on the International Space Station and lunar research with NASA's acting chief, the first such face-to-face meeting in more than seven years. Dmitry Bakanov, the director of the state space corporation Roscosmos, met Thursday with NASA's new acting administrator, Transportation Secretary Sean Duffy, on a visit to attend the planned launch of a U.S.-Japanese-Russian crew to the space station. The launch was delayed by weather until Friday, when it blasted off successfully. Roscosmos said Bakanov and Duffy discussed 'further work on the International Space Station, cooperation on lunar programs, joint exploration of deep space and continued cooperation on other space projects.' Once bitter rivals in the space race during the Cold War, Roscosmos and NASA cooperated on the space station and other projects. That relationship was beset with tensions after Moscow sent troops into Ukraine in 2022, but Washington and Moscow have continued to work together, with U.S. and Russian crews continuing to fly to the orbiting outpost on each country's spacecraft. Plans for broader cooperation, including possible Russian involvement in NASA's Artemis program of lunar research, have fallen apart. As Russia has become increasingly reliant on China for its energy exports and imports of key technology amid Western sanctions, Roscosmos has started cooperation with China on its prospective lunar mission. Speaking to Russian reporters after the talks with Duffy, Bakanov said that they agreed to keep working on keeping the space station in operation to the end of the decade. 'Our experts will now start working on those issues in details,' Bakanov said, praising Duffy for giving a green light for those contacts 'despite geopolitical tensions.' The Russian space chief added that he and Duffy will report the results of the meeting to Russian President Vladimir Putin and President Donald Trump to secure their blessing for potential space cooperation. 'In view of the difficult geopolitical situation, we will need to receive the necessary clearance from the leaders of our countries,' Bakanov said. He added he invited Duffy to visit Moscow and the Russia-leased Baikonur launch facility in Kazakhstan for the launch of another Russia-U.S. crew to the space station scheduled for November. 'I will put my efforts into keeping the channel of cooperation between Russia and the U.S. open, and I expect NASA to do the same,' Bakanov said.
Gizmodo
an hour ago
- Gizmodo
The Films and Shows You Should Be Streaming in August 2025
A new era of streaming selections is here. For the past several years, our monthly column, the Nerd's Watch, has been the place to find out all the best genre titles coming to the biggest streaming services. It wasn't a complete list. We just posted the titles we think you'd care about, but it was still long, and frankly, it was hard to pick out the best of the best. Months before the new remake with Jack Black and Paul Rudd, revisit the iconic camp classic with Ice Cube and Jennifer Lopez. It wasn't meant to be a camp classic, but it is now. Groundhog Day is one of those movies that just gets better and better the more you watch it. It's so expertly put together, so funny, so heartfelt. Just a true modern classic. We're onto our third Jurassic Park trilogy, but the original—Jurassic Park, The Lost World, and the underrated Jurassic Park III—are all reemerging on Netflix this month. Just in time for its 40th anniversary, the John Hughes comedy about two nerds who create a woman in a computer is popping up on two streamers. It's incredibly dated but also, thanks to John Hughes, still pretty delightful. Call them the Paul Walker years. The first seven Fast and Furious movies are all coming to Netflix (as well as Hobbs and Shaw), and you can make an argument that it was the passing of Walker, during Furious 7, that derailed the whole thing. Hopefully things get back up to speed in the future, but at least we'll always have these movies (and Hobbs and Shaw, unfortunately). The star-studded adaptation of the iconic Douglas Adams novel is nowhere near as good as the source material, but is anything? That the movie shared even a sliver of the genius and fun of the novel makes this one worth watching. Remember when Aaron Taylor-Johnson and Chloë Grace Moretz co-starred in one of the best superhero movies ever, alongside Nicolas Cage, and directed by Matthew Vaughn? Well, if not, now is the time to watch it again. J.J. Abrams writes and directs this Amblin-inspired tale of a group of kids who film a train crash, only to realize it's at the center of mysterious happenings around town. I've been meaning to revisit this one. One of the weirdest movies you'll see this year is this Stephen King adaptation, produced by James Wan and directed by Osgood Perkins. It's about a family tied in with a toy monkey that kills people seemingly at random. It's super violent and super funny. I'm writing this one more for myself than anyone else. Stranger Things star Finn Wolfhard co-directed this camp-based slasher movie that looks like a lot of fun. I missed it in theaters but definitely will check it out on streaming. Please refer to the above video. From Anna Boden and Ryan Fleck, the directors of Captain Marvel, comes this 'freaky' retro anthology starring Pedro Pascal, Ben Mendelsohn, Dominique Thorne, and other actors who aren't in Marvel movies. You may have missed it, but earlier this year, A24 released this very unique and gorgeous film about a seemingly regular rural town that's thrown into peril because of a group of nearby creatures. Creatures that one of the young women in the town becomes friends with. Willem Dafoe is among the stars. It'll be about a year until we next see James Gunn's DC Universe on the big screen, but before then, it'll be very active on HBO Max. First up, season two of the irreverent Peacemaker starring John Cena. It ties directly into the events of Superman and pushes the whole narrative forward. Have you ever wanted to know more about Wakanda in the Marvel Cinematic Universe? Well, this new animated series is just the ticket. I feel like I'm in Edge of Tomorrow with how I always repeat myself, but here it goes again. Every time Edge of Tomorrow, the Tom Cruise-Emily Blunt time loop sci-fi action film, appears on a streamer, I will let you know. If you stream it, we will watch. It's not quite Edge of Tomorrow, but if you want another super solid Tom Cruise sci-fi film, this one from Joseph Kosinski, the director of Tron: Legacy, Top Gun: Maverick, and F1, well, here you go. After a season with equal parts character and carnage, the video game adaptation starring Anthony Mackie is back. And, this season, it's all about the car battle royale that made the series so popular. One of the more underrated films of 2024 was this incredibly visceral action film starring and directed by Dev Patel. Highly recommended. Spike Jonze directs, Charlie Kaufman writes, and Nicolas Cage stars alongside Meryl Streep, Chris Cooper, and others. Not many movies could live up to that incredible roster, but this one does. There have been seven Paranormal Activity movies, and the first six (1, 2, 3, 4, Ghost Dimension, and Marked Ones) are all coming to Paramount+. Some are better than others, but it's a really strong, scary, found-footage franchise. Jim Carrey stars as a man who lives a pretty great life until he figures out he's the star of the world's largest reality TV series. A modern classic that gets better and better with age. One of those 1990s slashers that came out in the wake of Scream and has its fans, as well as its haters. We're in the first camp, what about you? Weeks after becoming probably the first indie horror movie to get its own corn maze at San Diego Comic-Con, the horror movie with the perfect, direct title is coming to streaming. Want more io9 news? Check out when to expect the latest Marvel, Star Wars, and Star Trek releases, what's next for the DC Universe on film and TV, and everything you need to know about the future of Doctor Who.
